Over‐expression of Dyrk1A affects bleeding by modulating plasma fibronectin and fibrinogen level in mice
Journal of Cellular and Molecular Medicine · 2023
DOI: 10.1111/jcmm.17817 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2023. Verfasst von Guillaume Postic und 15 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, BFA, UMR 8251, CNRS, ERLU1133, Paris, France. Hauptthemen laut MEDLINE: Down Syndrome, Thrombocytopenia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche.
Abstract (Originalsprache)
Down syndrome is the most common chromosomal abnormality in humans. Patients with Down syndrome have hematologic disorders, including mild to moderate thrombocytopenia. In case of Down syndrome, thrombocytopenia is not associated with bleeding, and it remains poorly characterized regarding molecular mechanisms. We investigated the effects of overexpression of Dyrk1A, an important factor contributing to some major Down syndrome phenotypes, on platelet number and bleeding in mice. Mice overexpressing Dyrk1A have a decrease in platelet number by 20%. However, bleeding time was found to be reduced by 50%. The thrombocytopenia and the decreased bleeding time observed were not associated to an abnormal platelet receptors expression, to a defect of platelet activation by ADP, thrombin or convulxin, to the presence of activated platelets in the circulation or to an abnormal half‐life of the platelets. To propose molecular mechanisms explaining this discrepancy, we performed a network analysis of Dyrk1A interactome and demonstrated that Dyrk1A, fibronectin and fibrinogen interact indirectly through two distinct clusters of proteins. Moreover, in mice overexpressing Dyrk1A, increased plasma fibronectin and fibrinogen levels were found, linked to an increase of the hepatic fibrinogen production. Our results indicate that overexpression of Dyrk1A in mice induces decreased bleeding consistent with increased plasma fibronectin and fibrinogen levels, revealing a new role of Dyrk1A depending on its indirect interaction with these two proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université Paris Cité, BFA, UMR 8251, CNRS, ERLU1133, Paris, France.
- HITh, UMR_S1176, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, le Kremlin-Bicêtre, France.
- Université Paris Cité, BFA, UMR 8251, CNRS, Paris, France.
- Institut Médical Jérôme Lejeune, Paris, France.
- Université Paris Cité, IJM, UMR 7592, CNRS, Paris, France.
- Toxicology of Contaminants Unit, Fougeres Laboratory, French Agency for Food, Environmental and Occupational Health & Safety (ANSES), Fougeres, France.
ORCID-Profile: Thibaut Léger, Nathalie Janel
Förderung
- Agence Nationale de la Recherche
Zitieren
APA
Postic, G., Solarz, J., Loubière, C., Kandiah, J., Sawmynaden, J., Adam, F., Vilaire, M., Léger, T., Camadro, J. M., Victorino, D. B., Potier, M. C., Bun, E., Moroy, G., Kauskot, A., Christophe, O., & Janel, N. (2023). Over‐expression of Dyrk1A affects bleeding by modulating plasma fibronectin and fibrinogen level in mice. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.17817
Vancouver
Postic G, Solarz J, Loubière C, Kandiah J, Sawmynaden J, Adam F, et al. Over‐expression of Dyrk1A affects bleeding by modulating plasma fibronectin and fibrinogen level in mice. Journal of Cellular and Molecular Medicine. 2023. doi:10.1111/jcmm.17817
BibTeX
@article{Postic2023,
author = {Postic, Guillaume and Solarz, Jean and Loubière, Cécile and Kandiah, Janany and Sawmynaden, Jaysen and Adam, Frederic and Vilaire, Marie and Léger, Thibaut and Camadro, Jean-Michel and Victorino, Daniella Balduino and Potier, Marie-Claude and Bun, Eric and Moroy, Gautier and Kauskot, Alexandre and Christophe, Olivier and Janel, Nathalie},
title = {Over‐expression of Dyrk1A affects bleeding by modulating plasma fibronectin and fibrinogen level in mice},
journal = {Journal of Cellular and Molecular Medicine},
year = {2023},
doi = {10.1111/jcmm.17817}
}
EUVIMED